One in 20 Canadians report cost-related nonadherence.

Sufferers receive drastically different care depending on their home province or territory.

Consultation’s comment period closes.

Rising non-adherence rates linked to lack of prescription drug coverage among Indigenous populations in Canada.

Definitions used in studying hypertension are not universal.

Uncertainty remains regarding the role of private insurers.

Use of biologic medicine advocated for treatment of uncontrollable conditions.